News: Brokerage

Hudson Valley iCampus signs 35,124 s/f new leases/expansions

Pearl River, NY Hudson Valley iCampus has signed three new leases and two expansion agreements in the first quarter of 2024, totaling 35,124 s/f and having a value of over $4 million.

The lease transactions include:

• RK Pharma, Inc., an American multinational pharmaceutical and biotechnology corporation, leased an additional 22,584 s/f of stability chamber space in Building 100. RK Pharma also leased 82,975 s/f of laboratory, manufacturing, and office space in Buildings 215 and 215A.

• Allied Health Management Service Organization, LLC, a healthcare leader, leased 5,677 /f of laboratory space in Building 205. Michael Baraldi of Cushman & Wakefield represented the tenant. Robert Lella of Colliers represented Hudson Valley iCampus.

• Avon Products, Inc., an innovator in cosmetics, fragrances, and skincare products, leased 4,719 s/f of laboratory and office space in Building 205. Avon recently sold its 235,000 s/f, 10-acre Avon Innovation Center to Regeneron Pharmaceuticals. Lella of Colliers represented Hudson Valley iCampus.

• Armistead Mechanical, Inc. an industrial piping contractor and one of the largest employers of plumbers and pipefitters in New Jersey and the New York Hudson Valley region, leased 1,468 s/f for shop space in Building 205.

• Olaplex Inc. , one of the largest independent hair care brands in the world with over 100 worldwide patents, continued to expand its footprint in Building 205 to 11,612 s/f of laboratory and office space by adding 676 s/f.

“Many of the deals were for laboratory uses,” said Jamie Schwartz, president of Hudson Valley iCampus. “Although the headlines report Life Sciences and Biotech investments slowing due to high interest rates and other factors, we continue to experience brisk leasing activity from both large and small companies.”

Hudson Valley iCampus attributes its success to having “plug and play” laboratory, manufacturing, and support space available for immediate occupancy. For example, Building 205, a 125,000 s/f, tenant-ready laboratory building, was 40% leased two years ago, and now it is 100% leased. Schwartz anticipates this leasing activity to continue in 2024.

READ ON THE GO
DIGITAL EDITIONS
Subscribe
Columns and Thought Leadership
The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

The anticipated effect of Basel III and ISO 20022 implementation on commercial real estate - by Michael Zysman

July 1, 2025 is the deadline for US banks to begin to adopt Basel III banking standards and July 14, 2025 is the deadline for U.S. banks to adopt ISO 20022 messaging standards. Both will have a significant effect on the banking and commercial real estate (CRE) finance sectors.
Tri-state capital  migrates nationally amid  regulation pressure - by Reese Weaver

Tri-state capital migrates nationally amid regulation pressure - by Reese Weaver

New York tri-state multifamily investors are increasingly reallocating capital to less-regulated markets across the U.S. as rent control and legislative risk erode returns at home. With over 60% of New York City’s rental housing stock classified as rent-stabilized, the traditional value-add model — buying under-performing buildings,

A fresh start - by Shallini Mehra and Amit Doshi

A fresh start - by Shallini Mehra and Amit Doshi

For the past several years, the New York City multifamily housing market has been defined by disruption. The combined impact of the HSTPA rent laws and a sharply higher interest rate environment has fundamentally reduced
The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

The death of the generic offering memorandum: What buyers expect in 2025 - by Kimberly Zar Bloorian

There was a time when an offering memorandum (OM) was pretty bare bones, some photos, a few bullet points on income, and a rent roll thrown in at the back. That used to get the job done. Not anymore. In 2025, buyers are sharper, faster, and more selective. They’re looking